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Background
Diabetes mellitus is a leading cause of morbidity and
mortality in Western countries. To prevent diabetic
chronic complications, various trials have validated the
need for tight glycemic control [1]. Important laboratory
markers used in the follow-up of diabetic patients
include glycated hemoglobin (HbA1c) [2,3] and microal-
buminuria [3], an important predictor of diabetic
nephropathy.
The aim of this study is to evaluate HbA1c as a signif-
icant index of glycemic control, and to determine the
prevalence of microalbuminuria in elderly diabetic
patients in our geographic area.
Materials and methods
HbA1c levels were measured using a high-pressure
liquid chromatography methodology (HA 8160, Menar-
ini Diagnostics), and analysed in 352 consecutive dia-
betic patients (age: >41 years) within a two month time
period (September-October 2009). The optimal HbA1c
target for diabetic patients was considered <7%, as
recommended by the American Diabetes Association.
Urinary albumin levels were measured by an immuno-
turbidimetric assay (BN II, Dade Behring) in 226 conse-
cutive diabetic patients (age: >41 years) within the same
time period. Microalbuminuria was diagnosed if albumin
in urine samples was > 30 mg/L.
Results
Within the patients examined, the overall HbA1c mean
is 6.95% +1.51, and the overall prevalence of high
HbA1c (>7%), indicative of poor glycemic control, is
34.4%. Interestingly, the prevalence of patients with high
HbA1c is over 30% in any age range examined, with a
peak in the age range 61-70 (Table 1). However, while
the overall prevalence of microalbuminuria is 19.2%, in
agreement with data reported by the Italian Ministry of
Health, microalbuminuria is diagnosed in about 8% of
diabetics under 60 years, and in almost 30% of patients
over 60 years (Table 2).
Conclusions
Our data indicate that a sub-optimal glycemic control is
observed in more than 30% of the diabetics examined,
regardless of age. Furthermore, our data confirm that
older age is associated with an increased risk of microal-
buminuria and progressive impairment of renal function.
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Table 1
Age range and
number of patients
HbA1c (mean+SD) Patients with
HbA1c >7%
41-50 (n = 49) 6.58% + 1.82 16 (32.6%)
51-60 (n = 85) 7.10% + 1.74 27 (31.8%)
61-70 (n = 112) 7.14% + 1.53 46 (41.1%)
71 and over (n = 106) 6.86% + 1.07 32 (30.2%)
Table 2
Age range and number of
patients
Patients with
microalbuminuria
41-50 (n = 48) 4 (8.3%)
51-60 (n = 57) 5 (8.7%)
61-70 (n = 62) 17 (27.4%)
71 and over (n = 59) 17 (28.9%)
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